Quote:
Originally Posted by 'Hamas' Jenkins
Coagulopathies have been an unfortunate issue for many seriously ill COVID patients, and microvascular thrombosis has been indicated as a precipitating factor for respiratory failure among patients that die. All admitted patients should at the very least receive prophylactic doses of low molecular weight heparins (like enoxaparin) if they don't have a contraindication.
Those that demonstrate VTE/PE will need therapeutic doses and will likely be at increased risk of thrombosis for several weeks/months after discharge.
|
What a horrifying thought that is, to be under 40 and receiving heparin because of this ****ed up virus.